Cargando…
Histone Signatures Predict Therapeutic Efficacy in Breast Cancer
Objective: Regulatory abnormalities caused by chromatin modifications are being increasingly recognized as contributors to cancer. While many molecularly targeted drugs have the potential to revert these modifications, their precise mechanism of action in cellular reprogramming is not known. Methods...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
IEEE
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207876/ https://www.ncbi.nlm.nih.gov/pubmed/32412527 http://dx.doi.org/10.1109/OJEMB.2020.2967105 |